Squarepoint Ops LLC Inmune Bio, Inc. Transaction History

Squarepoint Ops LLC

$57 Billion
Q1 2024

A detailed history of Squarepoint Ops LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 13,441 shares of INMB stock, worth $108,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,441

Holding current value

$108,468

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 15, 2024	BUY	$10.53 - $14.01 $141,533 - $188,308	13,441 New	13,441 $157,000
Q1 2023 May 15, 2023	BUY	$6.01 - $10.18 $78,400 - $132,798	13,045 New	13,045 $84,000

Others Institutions Holding INMB

# of Institutions

Shares Held

2.88M

Call Options Held

44.6K

Put Options Held

3.5K

Vanguard Group Inc Valley Forge, PA

541K
Shares

$4.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

240K
Shares

$1.94 Million
0.0% of portfolio
Mai Capital Management

181K
Shares

$1.46 Million
0.02% of portfolio
Rhenman & Partners Asset Management Ab Stockholm, V7

178K
Shares

$1.44 Million
0.2% of portfolio
Geode Capital Management, LLC Boston, MA

171K
Shares

$1.38 Million
0.0% of portfolio

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $145M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account